TMC-649128

DB15152InvestigationalSmall molecule

TMC-649128 is under investigation in clinical trial NCT01391117 (TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity...

Formula / weight: C₁₈H₂₆N₆O₆ · 422.442 g/mol (avg)
Code names: TMC649128

Resolves to

Compound

UNII9GE48QZN6XCAS1019639-33-8

Structure

InChIKeyXJBILYMRFVHPJB-XJQUKVTJSA-NSMILESCC(C)C(=O)OC[C@]1(O[C@H]([C@@H](C)[C@@H]1OC(=O)C(C)C)N1C=CC(N)=NC1=O)N=[N+]=[N-]

Targets

P26664Genome polyprotein

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with TMC-649128, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account